via Seattle Children's Hospital Research Foundation 2009 Academic Report:
"TEOSS demonstrated that olanzapine and risperidone have significant side effects that limit their use. While molidone can cause symptoms similar to Parkinson disease, the two new drugs can cause explosive weight gain — up to 15 pounds in eight weeks — and put young people at risk for diabetes and heart disease. The study also found the new drugs are no more useful than the old drugs at reducing psychotic symptoms — and each is useful in only a fraction of cases." (emphasis mine) Read more here.
14 of 116 or 12% were "successfully treated" in TEOSS a small fraction at that!
This same man who is the lead author for the "Practice Parameters" for treating Schizophrenia in children and adolescents for The American Academy of Child and Adolescent Psychiatry; last updated in 2010. These parameters anticipate that 50% of the children prescribed neuroleptic drugs, called "antipsychotics," will develop Tardive Dyskinisia, a disabling condition which can be permanent--even if the child is withdrawn from the drug which caused it. This specific risk was never mentioned in the 4+ years Jon McClellan used my son in his Drug Trials without Informed Consent. "Increased pulse rate," is how he characterized the cardiac risks.
